Xlife Sciences Stock Forecast for 2023 - 2025 - 2030
Updated on 04/25/2024
Xlife Sciences Stock Forecast and Price Target
The average price target for Xlife Sciences's stock of CHF68.00 recently provided by leading analysts would represent a 97.67% upside from its last closing price if reached. This potential increase is based on a high estimate of CHF68.00 and a low estimate of CHF68.00.
97.67% Upside
Xlife Sciences Fair Value Forecast for 2023 - 2025 - 2030
In the last two years, Xlife Sciences's Price has seen a drop from CHF30.00 to CHF0.00 – a 100.00% decrease. In the next year, analysts believe that Fair Value will reach CHF0.00 – an increase of 100.00%. For the next six years, the forecast is for Fair Value to grow by 100.00%.
Xlife Sciences Revenue Forecast for 2023 - 2025 - 2030
Xlife Sciences's Revenue has seen impressive growth In the last three years, rising from CHF400.00k to CHF990.00k – a growth of 147.50%. According to 0 major analysts, Xlife Sciences's Revenue will fall by 22.65% in the next year, reaching CHF765.80k. Professionals believe that By 2030, Xlife Sciences's Revenue will fall to CHF855.67k– a 13.57% decrease from its current value.
.jpg)
Xlife Sciences EBITDA Forecast for 2023 - 2025 - 2030
In the last three years, Xlife Sciences's EBITDA has seen an increase, rising from CHF-3.09M to CHF-4.28M. This represents a growth of 38.51%. In the following year, 0 experts forecast that Xlife Sciences's EBITDA will decrease by 6.52%, to CHF-4.00M. Over the next seven years, experts predict that Xlife Sciences's EBITDA will grow at a rate of 3.81%.
Xlife Sciences EBIT Forecast for 2023 - 2025 - 2030
Xlife Sciences's EBIT has seen growth In the last three years, going from CHF-3.09M to CHF-20.31M – a gain of 557.28% 0 analysts predict Xlife Sciences's EBIT will decrease by 37.56% in the next year, reaching CHF-12.68M. By 2030, professionals predict that Xlife Sciences's EBIT will decrease by 27.46%, to CHF-14.73M.
Xlife Sciences EPS Price Prediction Forecast for 2023 - 2025 - 2030
In the last two years, Xlife Sciences's EPS has seen a drop from CHF2.00 to CHF0.00 – a 100.00% decrease. In the next year, analysts believe that EPS will reach CHF0.00 – an increase of 100.00%. For the next six years, the forecast is for EPS to grow by 100.00%.
.jpg)